🧬 VC Directory
Biotech venture capital firms back life sciences companies advancing drug discovery, diagnostics, genomics, and therapeutics. The biotech VC market is distinct from software investing — requiring deep scientific expertise, longer investment horizons of 7-12 years, and comfort with binary clinical trial outcomes. Leading biotech investors like Flagship Pioneering, ARCH Venture Partners, and OrbiMed manage multi-billion-dollar portfolios and often incubate companies internally before spinning them out. Key trends include AI-accelerated drug discovery, cell and gene therapies, mRNA platforms, and precision oncology. The market has seen record deal sizes, with companies like Moderna (Flagship) and Recursion Pharmaceuticals demonstrating the massive upside when platform approaches succeed. Biotech VCs evaluate scientific novelty, clinical pathway feasibility, regulatory strategy, and intellectual property moats.
69 firms
Founded 2002, invests in disruptive life, physical, and data sciences
Pre-seed firm guaranteeing funds in 10 business days.
Physician-led, immigrant-founded VC targeting healthcare inequities
Early-stage life sciences with 4:59 Initiative model.
Acts as VC and venture studio co-founding startups with 25-30% capital allocation.
Led by active AI practitioners Socher, Manning, Goldbloom.
Invests at concept stage, co-founding breakthrough life sciences platforms.
Technical frontier specialist led by ex-Microsoft strategy executives
Climate-focused agrifood fund with rare food-policy expertise
Focuses exclusively on AI-first companies in technical domains.
Leads mega-rounds for frontier-tech visions with 150+ platform team and media operations.
Dedicated bio and health fund within a16z, investing in founders applying engineering and computational approaches to biology and healthcare.
Seed and early-stage investor emphasizing biotech company creation.
Deliberate 60/40 tech/healthcare split with transparent partner scoring.
Contrarian n-of-1 investor across frontier sectors.
Venture firm powered by a network of top university students and recent graduates, scouting and investing in the next generation of founders.
Analytics-driven co-investor making rapid decisions using proprietary model.
Targets companies applying modern computation to agriculture, mining, and health.
Gets founders priority introductions to deeptech VCs and angel networks.
E2MC Ventures is a Los Angeles-based early-stage venture firm specializing in the space economy, investing in satellite technology, launch services, in-space manufacturing, and the broader ecosystem of technologies enabling a multi-planetary future. The firm focuses on pre-seed and seed stage companies where its deep aerospace network and technical expertise provide the most leverage. E2MC backs founders building infrastructure for the commercial space industry and adjacent deep tech sectors.
Fidelity-backed formation engine for gene therapy and rare diseases.
Operator-heavy team backing pre-product deep-tech moonshots.
Contrarian, founder-maximalist VC backing hard scientific breakthroughs.
Invests in purpose-driven entrepreneurs reinventing industries.
Google's financially-driven VC with design studio and ML scoring.
Alphabet's venture capital arm, investing in seed through growth-stage companies across technology, life sciences, and healthcare.
CIA-founded venture firm targeting national-security venture-backed startups.
Founded by Eric Schmidt; invests in sensors, ML, and robotics.
Deeptech seed fund investing across chips, chemicals, energy, robotics.
KittyHawk Ventures is a New York-based venture firm that invests across the capital stack, from frontier seed rounds all the way through pre-IPO growth equity, focusing on transformative technology companies in sectors including fintech, enterprise software, and aerospace. The firm takes a flexible, stage-agnostic approach that allows it to build concentrated positions in breakout companies over multiple rounds. KittyHawk is known for its long-term partnership model and willingness to back unconventional founders with bold visions.
Deep technology venture firm investing in emerging science and technology ventures in energy, healthcare, and defense.
New York-based deep tech investor backing science-driven companies in defense, robotics, space, and computational biology.
Evergreen fund integrated with $10B+ hedge-fund platform.
Hong Kong-based family office venture firm investing in life sciences, technology, and AI companies globally.
Serial founder-led with Signal platform and CEO Guild network.
Separate technology and healthcare practices with long-tenured teams.
Leading healthcare-dedicated investment firm with over $18B under management, investing across biotech, pharma, and medtech.
Healthcare-only platform spanning seed through IPO via public/private arms.
Boston seed investor supporting professional growth.
Deep technology venture fund investing in AI, robotics, and synthetic biology startups with transformative potential.
Multi-stage venture firm investing in healthcare and technology companies, with strong expertise in life sciences and enterprise software.
Deep tech venture firm investing in breakthrough scientific startups across energy, transportation, infrastructure, and health.
Crossover healthcare investment firm investing in public and private biotech and pharmaceutical companies.
Invests in very-early to early-stage AI startups with AI research ties.
Solo GP leveraging Google/Netflix/LinkedIn experience to back hard-tech.
Japan's largest venture capital firm, investing in technology and life sciences companies across Asia.
Healthcare and deep technology venture firm founded by former Google Ventures managing partner Bill Maris.
MIT-linked venture firm investing in tough tech companies solving the world's biggest problems across energy, health, and computing.
Drug-discovery company creator incubating orphan and rare disease treatments.
Focuses on enabling infrastructure for the space economy.
Venture capital firm with roots in the Rockefeller family, investing in technology and healthcare companies for over 50 years.
Healthcare-focused venture arm of Venrock, the Rockefeller family venture fund, investing in biotech and digital health.
Creates companies from in-house discovery labs with big-pharma discipline.
Leading venture capital firm with dedicated funds for crypto, bio, and AI. Known for their thesis-driven approach and extensive portfolio company support.
A life sciences venture capital firm focused on biopharmaceutical, diagnostic, and medical device investments. One of the longest-running healthcare-focused VCs in the US.
Venture capital firm investing in agtech, food tech, and biotechnology companies that address global food security and sustainability challenges. They focus on technologies that improve agricultural productivity and food system resilience.
Nashville-based venture capital firm exclusively focused on healthcare technology investments. Deep expertise in digital health, medical devices, and healthcare services technology.
JJDC is the venture capital arm of Johnson & Johnson, investing in breakthrough healthcare innovations across pharmaceuticals, medical devices, and consumer health. They focus on companies developing transformative solutions for patients worldwide.
Main Sequence Ventures is a deep tech venture capital firm spun out of CSIRO, Australia's national science agency. The firm invests in startups built on breakthrough science and technology, bridging the gap between research and commercialization.
One of the largest and most active venture capital firms globally with over 45 years of experience. Known for investing across all stages and sectors with particular strength in healthcare and technology.
Chicago-based venture capital firm investing in early-stage healthcare and technology companies. Known for their deep industry expertise and strategic partnerships.
Life sciences venture capital firm investing in biotechnology, pharmaceutical, and medical technology companies. Focuses on translating breakthrough scientific discoveries into transformational medicines and healthcare solutions.
Polytech Ventures is a Swiss early-stage venture capital firm that invests in deep technology startups emerging from leading European universities and research labs. The firm focuses on companies with strong IP and technical differentiation.
A clinical-stage biopharma company that discovers and develops medicines for devastating diseases. Operates a unique model combining venture creation with drug development.
Roche's strategic investment arm focused on early-stage companies developing breakthrough healthcare technologies. Invests in innovative therapeutics, diagnostics, and digital health solutions that align with Roche's strategic priorities.
A European deep tech fund investing in seed-stage companies at the intersection of science and technology. Portfolio spans AI, quantum, biotech, and advanced materials.
A leading life sciences venture capital firm investing in biotech, pharma, and medical devices. With offices in the US and Europe, Sofinnova has backed numerous successful therapeutics companies.
A Swiss venture capital firm investing in European deep tech and life sciences startups. One of the most active investors in the Swiss startup ecosystem.
The venture and growth equity arm of Wellington Management, one of the world's largest independent investment management firms with over $1 trillion in AUM.